Balchem (BCPC) Q1 FY26 earnings call

Balchem delivered a strong start to the year with record Q1 FY26 financial results, driven by healthy demand across all segments and successful market penetration of its specialty nutrients. The company continues to leverage its formulation expertise and branded ingredients, particularly VitaCholine, while navigating geopolitical and macroeconomic dynamics, including rising input costs, through strategic pricing and supply chain management. Management remains confident in sustained top and bottom-line growth for the remainder of 2026.